{"id":34,"date":"2023-07-04T15:10:18","date_gmt":"2023-07-04T19:10:18","guid":{"rendered":"http:\/\/tris.sambrownprojects.com\/?page_id=34"},"modified":"2024-08-20T15:38:16","modified_gmt":"2024-08-20T19:38:16","slug":"clinical-publications","status":"publish","type":"page","link":"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/","title":{"rendered":"Clinical Publications"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text css=&#8221;.vc_custom_1692361051881{margin-bottom: 0px !important;}&#8221;]<div class=\"porto-block\" data-id=\"447\">[vc_row full_width=\"stretch_row\" video_bg=\"yes\" video_bg_url=\"\/wp-content\/uploads\/2023\/07\/Interior_WhoWeAre-Optimized.mp4\" wrap_container=\"yes\" conditional_render=\"%5B%7B%22value_role%22%3A%22administrator%22%7D%5D\" el_class=\"subpage-banner subpage-who-we-are\"][vc_column width=\"1\/2\"][vc_custom_heading field_dynamic_source=\"post_info\" font_container=\"tag:h1|text_align:left\" use_theme_fonts=\"yes\" enable_field_dynamic=\"true\" field_dynamic_content=\"post_title\"][\/vc_column][vc_column width=\"1\/2\"][\/vc_column][\/vc_row][vc_row full_width=\"stretch_row\" wrap_container=\"yes\" conditional_render=\"%5B%7B%22value_role%22%3A%22administrator%22%7D%5D\" el_class=\"subpage-nav hide-mobile\"][vc_column]<div class=\"widget_sidebar_menu main-sidebar-menu wpb_custom_fa56fd63c3b694fcdb3812eb30a338f1\"><div class=\"sidebar-menu-wrap\"><ul id=\"menu-subnav-pipeline\" class=\"sidebar-menu\"><li id=\"nav-menu-item-1030\" class=\"active-pipline menu-item menu-item-type-post_type menu-item-object-page  narrow \"><a href=\"https:\/\/www.trispharma.com\/pipeline\/\">Overview<\/a><\/li>\n<li id=\"nav-menu-item-2639\" class=\"menu-item menu-item-type-post_type menu-item-object-page  narrow \"><a href=\"https:\/\/www.trispharma.com\/pipeline\/adhd\/\">ADHD Pipeline<\/a><\/li>\n<li id=\"nav-menu-item-2641\" class=\"menu-item menu-item-type-post_type menu-item-object-page  narrow \"><a href=\"https:\/\/www.trispharma.com\/pipeline\/pain\/\">Pain Pipeline<\/a><\/li>\n<li id=\"nav-menu-item-2640\" class=\"menu-item menu-item-type-post_type menu-item-object-page  narrow \"><a href=\"https:\/\/www.trispharma.com\/pipeline\/other-cns-disorders\/\">Other CNS Disorders<\/a><\/li>\n<li id=\"nav-menu-item-1031\" class=\"menu-item menu-item-type-post_type menu-item-object-page  narrow \"><a href=\"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/\">Clinical Publications<\/a><\/li>\n<\/ul><\/div><\/div>[\/vc_column][\/vc_row]<\/div>[\/vc_column_text][\/vc_column][\/vc_row][vc_row css=&#8221;.vc_custom_1691650658122{margin-bottom: 0px !important;}&#8221; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221; el_class=&#8221;subpage-first-row subpage-first-row-text&#8221;][vc_column][vc_column_text css=&#8221;.vc_custom_1714558737354{margin-bottom: 0px !important;}&#8221;]<\/p>\n<h2>Our medicines and pipeline are supported by scientific, peer-reviewed publications that reinforce the value of the therapeutics we develop.<\/h2>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row wrap_container=&#8221;yes&#8221; equal_height=&#8221;yes&#8221; content_placement=&#8221;middle&#8221; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221; css=&#8221;.vc_custom_1692708120263{border-bottom-width: 2px !important;border-bottom-color: #dbdbdb !important;border-bottom-style: solid !important;}&#8221; el_class=&#8221;spacing-left-right press-release-section-title&#8221;][vc_column width=&#8221;1\/4&#8243; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221;][vc_column_text el_class=&#8221;featured-pressrelease-title&#8221;]FEATURED PUBLICATION[\/vc_column_text][\/vc_column][vc_column width=&#8221;3\/4&#8243;][\/vc_column][\/vc_row][vc_row wrap_container=&#8221;yes&#8221; equal_height=&#8221;yes&#8221; content_placement=&#8221;middle&#8221; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221; el_class=&#8221;spacing-left-right press-release-news&#8221; css=&#8221;.vc_custom_1717216008941{padding-bottom: 30px !important;}&#8221;][vc_column width=&#8221;1\/4&#8243; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221;][vc_single_image image=&#8221;1732&#8243; img_size=&#8221;full&#8221; el_class=&#8221;news-thumb&#8221;][\/vc_column][vc_column width=&#8221;3\/4&#8243; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221; css=&#8221;.vc_custom_1691391654196{padding-top: 10px !important;}&#8221;][vc_column_text css=&#8221;&#8221; el_class=&#8221;text-skyblue icon-set featured-publication-text&#8221;]<\/p>\n<h2>Sallee FR, Palumbo DR, Abbas R, Berry SA, Puthili SP, Kathala KK. Effect of food intake on the pharmacokinetics of a novel methylphenidate extended-release oral suspension for attention deficit hyperactivity disorder. <em>Clin Pharmacol Drug Dev<\/em>. 2017;6(5):47<\/h2>\n<h4><a href=\"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/epdf\/10.1002\/cpdd.366\" target=\"_blank\" rel=\"noopener\">VIEW ON WEBSITE<img decoding=\"async\" src=\"\/wp-content\/uploads\/2023\/07\/arrow_back.png\" alt=\"Arrow Icon\" \/><\/a><\/h4>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row el_class=&#8221;publication-title-space&#8221; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221;][vc_column][vc_column_text]<strong>Methylphenidate Extended-Release Oral Suspension<\/strong>[\/vc_column_text][\/vc_column][\/vc_row][vc_row el_class=&#8221;publications-list&#8221; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221;][vc_column]<ul id=\"porto-info-list80522724066dd0534ca01d\" class=\"porto-info-list  wpb_custom_2470fd4f9162ce1f73c94a8a2b72b3bf\"><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1087054714533191\" target=\"_blank\" rel=\"noopener\">Robb AS, Findling RL, Childress AC, Berry SA, Belden HW, Wigal SB. Efficacy, safety, and tolerability of a novel methylphenidate extended-release oral suspension (MEROS) in ADHD. <em>J Atten Disord<\/em>. 2017;21(14):1180-1191.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/epdf\/10.1002\/cpdd.366\" target=\"_blank\" rel=\"noopener\">Sallee FR, Palumbo DR, Abbas R, Berry SA, Puthili SP, Kathala KK. Effect of food intake on the pharmacokinetics of a novel methylphenidate extended-release oral suspension for attention deficit hyperactivity disorder. <em>Clin Pharmacol Drug Dev<\/em>. 2017;6(5):47<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3696913\/\" target=\"_blank\" rel=\"noopener\">Wigal SB, Childress AC, Belden HW, Berry SA. NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit\/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study.<em> J Child Adolesc Psychopharmacol<\/em>.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21904089\/\" target=\"_blank\" rel=\"noopener\">Childress AC, Sallee FR, Berry SA. single-dose pharmacokinetics of nwp06, an extended-release methylphenidate suspension, in children and adolescents with ADHD. <em>Postgrad Med<\/em>. 2011;123(5):80-88.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20861586\/\" target=\"_blank\" rel=\"noopener\">Childress AC, Berry SA. The single-dose pharmacokinetics of NWP06, a novel extended-release methylphenidate oral suspension. <em>Postgrad Med<\/em>. 2010;122(5):35-41.<\/a><\/div><\/li><\/ul>[\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<strong>Methylphenidate Extended-Release Tablet<\/strong>[\/vc_column_text][\/vc_column][\/vc_row][vc_row el_class=&#8221;publications-list&#8221; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221;][vc_column]<ul id=\"porto-info-list78180158266dd0534ca677\" class=\"porto-info-list  wpb_custom_2470fd4f9162ce1f73c94a8a2b72b3bf\"><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29703430\/\" target=\"_blank\" rel=\"noopener\">Abbas R, Childress AC, Nagraj B, et al. Relative bioavailability of methylphenidate extended-release chewable tablets chewed versus swallowed whole. <em>Clin Ther<\/em>. 2018;40(5):733-740.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5994665\/\" target=\"_blank\" rel=\"noopener\">Wigal SB, Childress A, Berry SA, et al. Optimization of methylphenidate extended-release chewable tablet dose in children with ADHD: open-label dose optimization in a laboratory classroom study. <em>J Child Adolesc Psychopharmacol<\/em>. 2018;28(5):314-321.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5651935\/\" target=\"_blank\" rel=\"noopener\">Wigal SB, Childress AC, Berry SA, et al. Efficacy and safety of a chewable methylphenidate extended-release tablet in children with attention deficit\/hyperactivity disorder. <em>J Child Adolesc Psychopharmacol<\/em>. 2017 ;27(8):690-699.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27021606\/\" target=\"_blank\" rel=\"noopener\">Abbas R, Palumbo D, Walters F, Belden H, Berry SA. Single-dose pharmacokinetic properties and relative bioavailability of a novel methylphenidate extended-release chewable tablet compared with immediate-release methylphenidate chewable tablet. <em>Clin Ther<\/em>. 2016;38(5):1151-1157.<\/a><\/div><\/li><\/ul>[\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<strong>Amphetamine Extended-Release Oral Suspension<\/strong>[\/vc_column_text][\/vc_column][\/vc_row][vc_row el_class=&#8221;publications-list&#8221; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221;][vc_column]<ul id=\"porto-info-list212974255266dd0534ca9b3\" class=\"porto-info-list  wpb_custom_2470fd4f9162ce1f73c94a8a2b72b3bf\"><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/DDFA54D24504E90806F9FE7480280E64\/S1092852919001676a.pdf\/singledose_pharmacokinetics_of_amphetamine_extendedrelease_tablets_compared_with_amphetamine_extendedrelease_oral_suspension.pdf\" target=\"_blank\" rel=\"noopener\">Pardo A, Kando JC, King TR, Rafla E, Herman BK. Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension. <em>CNS Spectr<\/em>. 2020;22:1-8.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31027435\/\" target=\"_blank\" rel=\"noopener\">Herman BK, Bouhajib M, King TR, Kando JC, Pardo A. Single-dose pharmacokinetics of amphetamine extended-release oral suspension in healthy adults. <em>J Atten Disord<\/em>. 2021. doi:10.1177\/1087054719841131.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6362322\/\" target=\"_blank\" rel=\"noopener\">Childress AC, Kando JC, King TR, Pardo A, Herman BK. Early-onset efficacy and safety pilot study of amphetamine extended-re\/ease oral suspension in the treatment of children with attention-deficit\/hyperactivity disorder. <em>J Child Adolesc Psychopharmacol<\/em>. 2<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5994670\/\" target=\"_blank\" rel=\"noopener\">Childress AC, Wigal SB, Brams MN, et al. Efficacy and safety of amphetamine extended-release oral suspension in children with attention-deficit\/hyperactivity disorder. <em>J Child Adolesc Psychopharmacol<\/em>. 2018;28(5):306-313.<\/a><\/div><\/li><\/ul>[\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<strong>Full, Dual Nociceptin\/Orphanin FQ Peptide (NOP) Receptor and \u00b5-Opioid Peptide (MOP) Receptor (Dual-NMR) Agonist<\/strong>[\/vc_column_text][\/vc_column][\/vc_row][vc_row el_class=&#8221;publications-list&#8221; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221;][vc_column]<ul id=\"porto-info-list143914164166dd0534cac6d\" class=\"porto-info-list  wpb_custom_2470fd4f9162ce1f73c94a8a2b72b3bf\"><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"\/wp-content\/uploads\/2023\/11\/Compared-to-Tramadol-and-Oxycodone-in-Recreational-Opioid-Users.pdf\" target=\"_blank\" rel=\"noopener\">Apseloff G, Pardo A, Shram M, et al<em>. <\/em>Limited Oral Abuse Potential of Cebranopadol, a Novel Potent Analgesic, Compared to Tramadol and Oxycodone in Recreational Opioid Users. Presented at PAINWeek 2023.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"\/wp-content\/uploads\/2023\/11\/Pooled-Analysis-of-Clinical-Opiate-Withdrawl-Scales.pdf\" target=\"_blank\" rel=\"noopener\">Fam D, Pardo A, Hackworth J. Cebranopadol, a Novel Potent Analgesic: Pooled Analysis of Clinical Opiate Withdrawal Scales. Presented at PAINWeek 2022.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30927089\/\" target=\"_blank\" rel=\"noopener\">Tzschentke TM, Linz K, Koch T, Christoph T. Cebranopadol: A Novel First-in-Class Potent Analgesic Acting via NOP and Opioid Receptors. <em>Handb Exp Pharmacol.<\/em> 2019;254:367-398.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5761752\/\" target=\"_blank\" rel=\"noopener\">Christoph A, Eerdekens MH, Kok M, et al. Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial. <em>Pain<\/em>. 2017;158(9):1813-1824.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"\/wp-content\/uploads\/2023\/11\/Results-From-a-Study-in-Patients-With-Moderate-to-Severe-Pain-Following-Bunionectomy.pdf\" target=\"_blank\" rel=\"noopener\">Bothmer J, Scholz A, H\u00f6schen K, Daniels S. Cebranopadol, A Novel First-in-Class Analgesic: Results From a Study in Patients With Moderate to Severe Pain Following Bunionectomy. Presented at PAINWeek 2016.<\/a><\/div><\/li><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><img decoding=\"async\" class=\"porto-info-icon\" src=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2023\/08\/\ud83e\udd86-icon-_document_.png\" width=\"21\" height=\"24\" alt=\"List Icon\" \/><div class=\"porto-info-list-item-desc\"><a href=\"\/wp-content\/uploads\/2023\/11\/Cebranopadol_JPET-20142557230.pdf\" target=\"_blank\" rel=\"noopener\">Linz K, Christoph T, Tzschentke TM, et al. <em>Cebranopadol<\/em>: A Novel Potent Analgesic Nociceptin\/Orphanin FQ Peptide and Opioid Receptor Agonist. <em>J Pharmacol Exp Ther<\/em>. 2014;349:535-548.<\/a><\/div><\/li><\/ul>[\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=&#8221;.vc_custom_1692880132392{padding-bottom: 30px !important;}&#8221; el_class=&#8221;publication-footernote&#8221;]<em>Please see Full Prescribing Information and Medication Guide for <a href=\"\/wp-content\/uploads\/2023\/08\/DYANAVELXR_pi-2.pdf\" target=\"_blank\" rel=\"noopener\">Dyanavel XR, <\/a><a href=\"\/wp-content\/uploads\/2023\/08\/QuillivantXR_pi-1.pdf\" target=\"_blank\" rel=\"noopener\">Quillivant XR<\/a> and <a href=\"\/wp-content\/uploads\/2023\/08\/QuilliChewER_pi-1.pdf\" target=\"_blank\" rel=\"noopener\">QuilliChew ER<\/a>, including Boxed Warning about Abuse and Dependence.<\/em><\/p>\n<p><em>DYANAVEL is a registered trademark of Tris Pharma, Inc. Quillivant XR and QuilliChew ER are registered trademarks of NextWave Pharmaceuticals, Inc. NextWave Pharmaceuticals, Inc. is a wholly owned subsidiary of Tris Pharma, Inc.<\/em>[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; wrap_container=&#8221;yes&#8221; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221; el_class=&#8221;bottom-collout-publications gradient-global mob-footercallout&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221; el_class=&#8221;text-white&#8221;]<\/p>\n<h2>Our medicines and pipeline are supported by scientific, peer-reviewed publications that reinforce the value of the therapeutics we develop.<\/h2>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text css=&#8221;.vc_custom_1692361051881{margin-bottom: 0px !important;}&#8221;][\/vc_column_text][\/vc_column][\/vc_row][vc_row css=&#8221;.vc_custom_1691650658122{margin-bottom: 0px !important;}&#8221; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221; el_class=&#8221;subpage-first-row subpage-first-row-text&#8221;][vc_column][vc_column_text css=&#8221;.vc_custom_1714558737354{margin-bottom: 0px !important;}&#8221;] Our medicines and pipeline are supported by scientific, peer-reviewed publications that reinforce the value of the therapeutics we develop. [\/vc_column_text][\/vc_column][\/vc_row][vc_row wrap_container=&#8221;yes&#8221; equal_height=&#8221;yes&#8221; content_placement=&#8221;middle&#8221; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221; css=&#8221;.vc_custom_1692708120263{border-bottom-width: 2px !important;border-bottom-color: #dbdbdb !important;border-bottom-style: solid !important;}&#8221; el_class=&#8221;spacing-left-right press-release-section-title&#8221;][vc_column width=&#8221;1\/4&#8243; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221;][vc_column_text el_class=&#8221;featured-pressrelease-title&#8221;]FEATURED PUBLICATION[\/vc_column_text][\/vc_column][vc_column width=&#8221;3\/4&#8243;][\/vc_column][\/vc_row][vc_row wrap_container=&#8221;yes&#8221; equal_height=&#8221;yes&#8221; content_placement=&#8221;middle&#8221; conditional_render=&#8221;%5B%7B%22value_role%22%3A%22administrator%22%7D%5D&#8221; [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":32,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-34","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\n<title>Clinical Publications | Tris Pharma<\/title>\n<meta name=\"description\" content=\"Learn about how Tris Pharma&#039;s medical advancements and pipeline are supported by scientific, peer-reviewed publications.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Publications | Tris Pharma\" \/>\n<meta property=\"og:description\" content=\"Learn about how Tris Pharma&#039;s medical advancements and pipeline are supported by scientific, peer-reviewed publications.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/\" \/>\n<meta property=\"og:site_name\" content=\"Tris Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-20T19:38:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.trispharma.com\/wp-content\/uploads\/2024\/05\/Tris_OGImage.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/\",\"url\":\"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/\",\"name\":\"Clinical Publications | Tris Pharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.trispharma.com\/#website\"},\"datePublished\":\"2023-07-04T19:10:18+00:00\",\"dateModified\":\"2024-08-20T19:38:16+00:00\",\"description\":\"Learn about how Tris Pharma's medical advancements and pipeline are supported by scientific, peer-reviewed publications.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.trispharma.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pipeline\",\"item\":\"https:\/\/www.trispharma.com\/pipeline\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Publications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.trispharma.com\/#website\",\"url\":\"https:\/\/www.trispharma.com\/\",\"name\":\"Tris Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.trispharma.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n","yoast_head_json":{"title":"Clinical Publications | Tris Pharma","description":"Learn about how Tris Pharma's medical advancements and pipeline are supported by scientific, peer-reviewed publications.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/","og_locale":"en_GB","og_type":"article","og_title":"Clinical Publications | Tris Pharma","og_description":"Learn about how Tris Pharma's medical advancements and pipeline are supported by scientific, peer-reviewed publications.","og_url":"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/","og_site_name":"Tris Pharma","article_modified_time":"2024-08-20T19:38:16+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.trispharma.com\/wp-content\/uploads\/2024\/05\/Tris_OGImage.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/","url":"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/","name":"Clinical Publications | Tris Pharma","isPartOf":{"@id":"https:\/\/www.trispharma.com\/#website"},"datePublished":"2023-07-04T19:10:18+00:00","dateModified":"2024-08-20T19:38:16+00:00","description":"Learn about how Tris Pharma's medical advancements and pipeline are supported by scientific, peer-reviewed publications.","breadcrumb":{"@id":"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.trispharma.com\/pipeline\/clinical-publications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.trispharma.com\/"},{"@type":"ListItem","position":2,"name":"Pipeline","item":"https:\/\/www.trispharma.com\/pipeline\/"},{"@type":"ListItem","position":3,"name":"Clinical Publications"}]},{"@type":"WebSite","@id":"https:\/\/www.trispharma.com\/#website","url":"https:\/\/www.trispharma.com\/","name":"Tris Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.trispharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/pages\/34"}],"collection":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/comments?post=34"}],"version-history":[{"count":25,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/pages\/34\/revisions"}],"predecessor-version":[{"id":3056,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/pages\/34\/revisions\/3056"}],"up":[{"embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/pages\/32"}],"wp:attachment":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/media?parent=34"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}